Savara Inc. · 4 hours ago
Vice President, Clinical Development
Savara Inc. is a clinical stage biopharmaceutical company focused on rare respiratory diseases. The Vice President, Clinical Development will serve as the medical lead and subject matter expert, responsible for driving the clinical development strategy for molgramostim nebulizer solution and overseeing clinical trial safety oversight.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Ensure an effective and high-performing clinical development function, including sufficient resources to meet the demands of the company
Oversee the Company's clinical development activities, including clinical trial design, implementation, conduct and reporting, safety surveillance and reporting, identification, selection and oversight of relevant clinical vendors
Provide input into clinical development plans and clinical trial protocols, including review of key trial-related documents, procedures, and analysis plans including informed consent forms, clinical research forms, statistical analysis plans, and clinical study reports
Oversee review of SAE reports with respect to medical accuracy, causality assessment, and expectation assessment
Function as (or provide oversight for) the medical monitor for selected studies, including medical oversight, pharmacovigilance review of medical accuracy, causality, and expectedness, and align scientific aspects of clinical development projects with expert advice and available clinical evidence
Collaborate with senior leaders to review and evaluate business development opportunities
In collaboration with Quality Assurance, oversee the creation, periodic updates and implementation of excellent clinical development procedures
Serve as the primary liaison with Clinical Operations to ensure timely delivery of milestones and data
Ensure cohesion with Medical Affairs and provide clinical support for publications, advisory boards, and presentations of results at medical congresses
Prepare or review documents for regulatory submissions, including clinical study reports, clinical & safety summaries and overviews, and Investigator's Brochures
Support business development activities by providing clinical input, technical expertise, and medical evaluation of new indications and business opportunities. Generate development plans and medical rationales for new products or indications
Keep apprised of medical and scientific knowledge within the assigned clinical area through literature review, participation in scientific meetings, and frequent interactions with clinical experts
Maintain and expand the global clinical network with medical/scientific experts and key opinion leaders in the field
Hire, provide feedback, monitor and direct work, manage performance, and proactively coach direct reports
Other duties and projects as assigned
Qualification
Required
Doctorate degree (MD, DO) with 10+ pharmaceutical/biotechnology/clinical development experience, preferably in Pulmonary Medicine
Ability to understand and effectively communicate scientific and medical information
Proven leadership skills
Excellent written and oral communication skills are imperative
Ability to anticipate and adapt to change; strong interpersonal skills commensurate with the need to work closely with partners, investigators, contractors, consultants, and team members across functions
Ability to communicate well with health care professionals
Ability to establish strong relationships with peer groups, professional organizations, and other outside parties
Preferred
Board certification in pulmonary medicine desirable
Benefits
Medical, dental and vision coverage
FSA for health care and dependent care
Paid time off and paid holidays, including a week-long winter shutdown
Paid parental leave
401(k) with highly competitive match
Life, AD&D, STD and LTD insurance coverage
Company
Savara Inc.
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases.
Funding
Current Stage
Public CompanyTotal Funding
$668.6MKey Investors
RTW InvestmentsHercules CapitalSilicon Valley Bank
2025-10-29Post Ipo Equity· $149.5M
2025-10-29Post Ipo Debt· $75M
2025-03-26Post Ipo Debt· $30M
Recent News
2025-12-17
Company data provided by crunchbase